# Colgate share price today (Colgate-Palmolive (India) Ltd, NSE: COLPAL)

> Colgate share price today: ₹1,631.70 at the NSE close on 3 November 2026, down 27.3% in a year. Colgate-Palmolive (India) (NSE: COLPAL) is worth ₹44,394 crore, trades at a P/E of 32.1 and has closed between ₹1,596.50 and ₹2,254.50 over the past 52 weeks. > Colgate-Palmolive (India) Ltd's share price has fallen more than its earnings. Earnings per share fell 7.8% in a year while the price moved −27.3%. COLPAL · FMCG - Personal Care · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting better, from the last 12 quarters
- Price: ₹1,631.70 (−27.3% in a year)
- P/E: 32.1× (lower than 100% of the last 11 years)
- Revenue (Sep 2026): ₹1,706 Cr (+12.2% on a year ago)
- Profit (Sep 2026): ₹342 Cr (+4.3% on a year ago)
- Operating margin: 28.0% (−3.0 points on a year ago)
- ROCE: 108%, FY26
- ROIC: 292.4%, against a 12.0% cost of capital: +280.4 points

The main question: foreign institutions moved −11.2 percentage points over 8 quarters while the business went the other way. ## What is the Colgate share price today? Colgate-Palmolive (India) Ltd's share price was ₹1,631.70 at the close on 3 November 2026. It has been falling for 97 weeks. That is 18.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,597 and ₹2,255, and at that close it sat 5% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 15 weeks running. Over the last 11 years the share price moved +93% while the NIFTY 500 moved +249%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 24 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Colgate this quarter? Three changes stood out: lowest operating margin in 15 quarters, highest quarterly revenue in 16 quarters and revenue up on a year earlier for 4 quarters in a row. 1. Lowest operating margin in 15 quarters Operating margin was 28% in the September 2026 quarter, against 31% a year earlier. 2. Highest quarterly revenue in 16 quarters Revenue of ₹1,706 crore in the September 2026 quarter is the highest of the last 16 quarters. 3. Revenue up on a year earlier for 4 quarters in a row In the September 2026 quarter revenue was ₹1,706 crore, +12.2% on a year earlier. ## What are Colgate's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Colgate reported revenue of ₹1,706 crore, up 12.2% from ₹1,520 crore a year earlier, and a profit of ₹342 crore, up 4.3% from ₹328 crore. ### Colgate results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹1,706 crore | ₹1,520 crore | +12.2% |
| Profit | ₹342 crore | ₹328 crore | +4.3% |
| Earnings per share | ₹12.56 | ₹12.04 | +4.3% |
| Operating margin | 28.0% | 31.0% | −3.0 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 17 August 2026, about April to June 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Colgate share price history? Colgate closed at ₹1,631.70 on 3 November 2026, down 27.3% from ₹2,243.00 a year earlier (31 October 2025) and up 7.2% over five years. Its highest weekly close since March 2016 was ₹3,764.05 on 27 September 2024. ### Colgate share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹1,605.00 | +1.7% |
| 1 month ago · 1 Oct 2026 | ₹1,735.00 | −6.0% |
| 6 months ago · 30 Apr 2026 | ₹2,096.20 | −22.2% |
| 1 year ago · 31 Oct 2025 | ₹2,243.00 | −27.3% |
| 3 years ago · 3 Nov 2023 | ₹2,104.95 | −22.5% |
| 5 years ago · 4 Nov 2021 | ₹1,521.90 | +7.2% |
| 10 years ago · 4 Nov 2016 | ₹984.15 | +65.8% |
| Earliest weekly close in our records · 4 Mar 2016 | ₹846.30 | +92.8% |
| Highest weekly close since March 2016 · 27 Sep 2024 | ₹3,764.05 | −56.7% |
| Lowest weekly close since March 2016 · 20 May 2016 | ₹808.90 | +101.7% |
| 52-week high (weekly close) · 27 Feb 2026 | ₹2,254.50 | −27.6% |
| 52-week low (weekly close) · 30 Oct 2026 | ₹1,596.50 | +2.2% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (561 weekly closes from 4 March 2016 to 3 November 2026.)

## What is the latest news on Colgate? 3 Nov 2026: Colgate closed at ₹1,631.70, up 1.7% on the week and down 6.0% on the month. 2 Nov 2026: ex-date for an interim dividend of ₹24 a share. ### Earlier

- Results for July to September 2026: Revenue up 12.2% and profit up 4.3% on a year earlier. - 17 Aug 2026: Colgate held its results call for April to June 2026. Management guided: Balanced growth across volume, mix and price rather than predominantly price-led growth. - 1 Jun 2026: ex-date for an interim dividend of ₹24 a share. ## What dividend does Colgate pay? Colgate paid ₹48 a share in regular dividends in the 12 months to 4 November 2026 (2 payments), a yield of 2.94% at the ₹1,631.70 close on 3 November 2026. The last was an interim dividend of ₹24 a share, ex-date 2 November 2026. ### Colgate dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 2 Nov 2026 | ₹24 | Interim | same day |
| 1 Jun 2026 | ₹24 | Interim | same day |
| 3 Nov 2025 | ₹24 | Interim | same day |
| 28 May 2025 | ₹27 | Interim | same day |
| 4 Nov 2024 | ₹24 | Interim | same day |
| 22 May 2024 | not readable | Dividend | 23 May 2024 |
| 6 Nov 2023 | ₹22 | Interim | same day |
| 19 May 2023 | ₹21 | Interim | 20 May 2023 |
| 31 Oct 2022 | ₹18 | Interim | 1 Nov 2022 |
| 5 May 2022 | ₹21 | Interim | 7 May 2022 |
| 1 Nov 2021 | ₹19 | Interim | 2 Nov 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Colgate-Palmolive (India) Ltd paid out 119% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Colgate management say on the latest results call? On the call for April to June 2026, held on 17 August 2026, Colgate's management guided: Balanced growth across volume, mix and price rather than predominantly price-led growth. > “To sum up, our objective, or goal, going forward is to drive growth ahead of profitability.”
> Jacob, on the call for April to June 2026

### What management guided

- Gross margins expected to remain within the current range, with price increases spaced out as costs are monitored. - Operating profit percentage may face short-term pressure; no fixed operating profit level will constrain premium brand spending. - Toothbrush growth to continue through availability, regimen, children, rural replacement and urban premium trade-up. - Palmolive partnership to build e-commerce and D2C performance, with progress assessed over the next 2-3 years. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/380/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 17 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Colgate's next results? When Colgate reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Premium toothpaste to keep outpacing core; check whether Total, Visible White Purple and Periogard produce repeat demand. - What to check (from the call)
- Premium toothpaste to keep outpacing core; check whether Total, Visible White Purple and Periogard produce repeat demand. - Gross-margin protection against upward-biased advertising; check whether operating profit pressure remains contained as premium spending rises. - Palmolive e-commerce and D2C partnership; check whether early green shoots become sustained brand and sales traction. - Rural oral-health activation; check whether daily-brushing improvement translates into broader toothpaste and toothbrush consumption. ## Which stock lists is Colgate on? Colgate is on 3 of our India lists: 52 week high & low, Dividend stocks and Small & mid cap stocks. - [52 week high & low 52-week position: At 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)
- [Dividend stocks Regular dividend yield (%): 3.05](https://www.sectoralpha.in/dividend-stocks-india)
- [Small & mid cap stocks Size rank in India: 210](https://www.sectoralpha.in/small-cap-stocks-india)

## Is Colgate profitable? Colgate-Palmolive (India) Ltd earned ₹342 Cr of net profit in the Sep 2026 quarter, +4.3% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹1,325 Cr. Over 10 years profit has grown 8.6% a year on average. That is 20.0% of the quarter's revenue. The same quarter a year earlier earned ₹328 Cr. For the full year, FY26 profit was ₹1,325 Cr (−7.8% on the year before). Why profit moved: revenue changed +12.2% on a year earlier and the margin moved −3.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +2.7% and revenue +8.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Colgate make, and is it growing? Colgate-Palmolive (India) Ltd reported ₹1,706 Cr of revenue in the Sep 2026 quarter, +12.2% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 10 years it has grown 4.5% a year on average. The last full year, FY26, came in at ₹6,035 Cr. The last four reported quarters add to ₹6,390 Cr. FY26 revenue was ₹6,035 Cr, −0.1% on the year before. Recent pace: the last four quarters grew +8.6% on average, against 4.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +8.7%, against +3.2% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +2.6%, against −3.7% a year (accelerating). ## How much of every ₹100 of sales does Colgate keep? Colgate-Palmolive (India) Ltd's operating margin was 28.0% in the Sep 2026 quarter, 3.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 19.0% and 33.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −2.9 percentage points on the year while gross margin changed +0.4 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Colgate's profit turning into cash? Over the last 3 years, 108% of Colgate-Palmolive (India) Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹1,806 Cr of operating cash against ₹1,325 Cr of profit. After ₹77.0 Cr of spending on assets, ₹1,729 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 108% of profit came in as cash: the cash cycle got 97 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Colgate's cash go? Colgate-Palmolive (India) Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −188 days in FY26, down from −91 days in FY21. It spent ₹250 Cr on assets over the last 3 years. Customers take 13 days to pay, and stock sits for 75 days on average. At FY26 sales of ₹6,035 Cr, each day of that cycle ties up about ₹16.5 Cr, so roughly −₹3,108 Cr is tied up in the business at any time. FY26: customers took 13 days to pay and stock sat for 75 days, about 2.5 months of sales sitting as stock, for a full cycle of −188 days, shorter than FY21's −91. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 75 days. Customers pay about 13 days after that. Suppliers are paid at 275 days. Together that makes the −188-day cycle. Spending on assets: ₹250 Cr over the last 3 years, against ₹481 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹27.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Colgate's P/E ratio, and how does it compare with its own history? Colgate-Palmolive (India) Ltd's P/E is 32.1×, about the lowest it has ever been. Its usual P/E (the middle reading) is 44.9×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹50.07. Why the multiple is where it is: over the past year earnings per share moved −7.8% while the price moved −27.3%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +1.4% a year; about +5.4% a year came from earnings growth and about −4.0 percentage points from the multiple (the market paying less); over 10 years the price moved +5.2% a year; about +8.4% a year came from earnings growth and about −3.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Colgate business getting better or worse? Colgate-Palmolive (India) Ltd's business is getting better. Profit growth hit its low 3 quarters ago at −9.2% and has recovered to +2.6%, with ROCE rising at 108.8%. This is based on 12 quarters of 4 measures. Why it matters: a lasting rise from a low is what this page is built to show. ## How much does Colgate earn on its capital? Colgate-Palmolive (India) Ltd earned a ROCE of 108% in FY26. That is up from a low of 65% in FY20. Its return on capital used (ROIC) is 280.4 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 22.0% net margin and 1.77× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 22.0% net margin × 1.77× asset turnover × 2.15× leverage (assets divided by equity) ≈ 83.7% on equity. The margin does most of the work; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 292.4% − 12.0% = +280.4 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. ## Does Colgate have too much debt? Colgate-Palmolive (India) Ltd has total debt of ₹49.0 Cr against shareholder equity of ₹1,618 Cr as of Sep 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.05 in FY22 to 0.03 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Colgate shareholding pattern? Foreign institutions cut their stake in Colgate-Palmolive (India) Ltd by 11.2 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 13.7% of the company. Domestic institutions moved +9.9 points over the same period, to 15.4%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −11.2 points over 8 quarters, to 13.7%; Domestic institutions: +9.9 points over 8 quarters, to 15.4%; Promoters: +0.0 points over 8 quarters, to 51.0%. Why the owners changed: foreign institutions moved −11.2 points and domestic institutions +9.9 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Colgate from balance-sheet trouble? For Colgate-Palmolive (India) Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Colgate rank in its industry? 51.0 out of 100, rank 6 of 12 in FMCG - Personal Care, with 85% of the evidence available. Colgate-Palmolive (India) Ltd scores 51.0 out of 100 against the 12 companies it is compared with in FMCG - Personal Care, ranking 6. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 12.5 + 21.6 + 8.4 + 8.5 = 51. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Colgate compared with? Colgate ranks 6 of 12 FMCG - Personal Care companies on the 4-Factor Sector Score, with 51.0 out of 100. 1. [Bajaj Consumer Care Ltd](https://www.sectoralpha.in/stocks/bajaj-consumer-care-ltd) BAJAJCON · quiet · Most evidence points up · 100% evidence 70.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 28% · Profit 84.6% · Operating margin change 7 points · 100% evidence Capital efficiency 19.2/25 · ROCE 30% · Operating margin 25% · 100% evidence Valuation 11.7/20 · P/E 19.3× · PEG 1.64 · 100% evidence Relative strength 6.5/20 · Lead over its industry 0.2% · Lead over NIFTY 500 -10.2% · 1 year 33.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 19.2 + 11.7 + 6.5 = 70.1 · What this means: Earnings are strong; relative strength in its sector is 0.2% and the one-year return is 33.5%. 2. [Hindustan Unilever Ltd](https://www.sectoralpha.in/stocks/hindustan-unilever-ltd) HINDUNILVR · basing · Most evidence points up · 100% evidence 69.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 9.5% · Profit 38% · Operating margin change -2 points · 100% evidence Capital efficiency 15.8/25 · ROCE 28.4% · Operating margin 22% · 100% evidence Valuation 17.2/20 · P/E 39.1× · PEG 0.72 · 100% evidence Relative strength 12.8/20 · Lead over its industry 1% · Lead over NIFTY 500 -9.9% · 1 year -21% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.4 + 15.8 + 17.2 + 12.8 = 69.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Marico Ltd](https://www.sectoralpha.in/stocks/marico-ltd) MARICO · quiet · Most evidence points up · 78% evidence 66.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 25.1% · Profit 15% · Operating margin change 1 points · 83% evidence Capital efficiency 17.9/25 · ROCE 47% · Operating margin 21% · 76% evidence Valuation 6.8/20 · P/E 55.1× · PEG n/a · 50% evidence Relative strength 17.4/20 · Lead over its industry 18.9% · Lead over NIFTY 500 6.5% · 1 year 11.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 24.4 + 17.9 + 6.8 + 17.4 = 66.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) GILLETTE · turning · Evidence leans up · 81% evidence 64.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.0/35 · Revenue 8% · Profit 18.4% · Operating margin change -1 points · 88% evidence Capital efficiency 18.1/25 · ROCE 90.7% · Operating margin 29% · 100% evidence Valuation 13.6/20 · P/E 34.5× · PEG 1.7 · 100% evidence Relative strength 10.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -5.5% · 1 year -21.5% · 25% evidence · 0 of 12 weeks ahead Exact sum: 23 + 18.1 + 13.6 + 10.1 = 64.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) PGHH · basing · Evidence leans up · 81% evidence 52.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue -1.6% · Profit -4.7% · Operating margin change -9 points · 88% evidence Capital efficiency 17.6/25 · ROCE 157% · Operating margin 19% · 100% evidence Valuation 13.3/20 · P/E 28.1× · PEG 1.77 · 100% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -27.7% · 1 year -48.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 13.9 + 17.6 + 13.3 + 7.5 = 52.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 6. Colgate-Palmolive (India) Ltd this page COLPAL · quiet · Evidence leans up · 85% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.5/35 · Revenue 8.7% · Profit 2.6% · Operating margin change -3 points · 100% evidence Capital efficiency 21.6/25 · ROCE 108% · Operating margin 28% · 100% evidence Valuation 8.4/20 · P/E 31.4× · PEG 6.07 · 100% evidence Relative strength 8.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -17.1% · 1 year -28.8% · 25% evidence · 0 of 12 weeks ahead Exact sum: 12.5 + 21.6 + 8.4 + 8.5 = 51 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) DABUR · basing · Evidence leans up · 81% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 7.4% · Profit 10.9% · Operating margin change 0 points · 88% evidence Capital efficiency 14.9/25 · ROCE 20.3% · Operating margin 20% · 100% evidence Valuation 9.1/20 · P/E 32.7× · PEG 5.04 · 100% evidence Relative strength 8.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.7% · 1 year -25% · 25% evidence · 0 of 12 weeks ahead Exact sum: 18.2 + 14.9 + 9.1 + 8.8 = 51 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Emami Ltd](https://www.sectoralpha.in/stocks/emami-ltd) EMAMILTD · basing · Evidence leans down · 96% evidence 43.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.0/35 · Revenue 2.8% · Profit -8.2% · Operating margin change -1 points · 88% evidence Capital efficiency 15.1/25 · ROCE 28.1% · Operating margin 22% · 100% evidence Valuation 8.9/20 · P/E 20.7× · PEG 2.99 · 100% evidence Relative strength 10.1/20 · Lead over its industry -3.2% · Lead over NIFTY 500 -13.6% · 1 year -32.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 9 + 15.1 + 8.9 + 10.1 = 43.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Zydus Wellness Ltd](https://www.sectoralpha.in/stocks/zydus-wellness-ltd) ZYDUSWELL · quiet · Evidence leans down · 96% evidence 39.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 66.3% · Profit -42.5% · Operating margin change -1 points · 88% evidence Capital efficiency 7.9/25 · ROCE 4.9% · Operating margin 17% · 100% evidence Valuation 6.0/20 · P/E 66.5× · PEG 1.75 · 100% evidence Relative strength 12.7/20 · Lead over its industry 12.9% · Lead over NIFTY 500 1.1% · 1 year -2.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 12.8 + 7.9 + 6 + 12.7 = 39.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) GODREJCP · quiet · Evidence leans down · 100% evidence 35.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 12.9% · Profit 8.6% · Operating margin change -1 points · 100% evidence Capital efficiency 10.3/25 · ROCE 18.8% · Operating margin 19% · 100% evidence Valuation 4.3/20 · P/E 39.4× · PEG 7.49 · 100% evidence Relative strength 2.9/20 · Lead over its industry -8.6% · Lead over NIFTY 500 -18.5% · 1 year -26.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 10.3 + 4.3 + 2.9 = 35.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Jyothy Labs Ltd](https://www.sectoralpha.in/stocks/jyothy-labs-ltd) JYOTHYLAB · quiet · Most evidence points down · 96% evidence 34.0 out of 100 Growth Capital Valuation Relative
12. [Polo Queen Industrial and Fintech Ltd](https://www.sectoralpha.in/stocks/polo-queen-industrial-and-fintech-ltd) PQIF · Too little evidence to rank firmly · 33% evidence 39.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [FMCG - Personal Care](https://www.sectoralpha.in/sectors/fmcg-personal-care), all 12 compared on one page. ## Which companies are close to Colgate in size? Colgate is the 5th largest of 12 FMCG - Personal Care companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Marico, Godrej Consumer Products and Dabur India. Just below it: Gillette India, Procter & Gamble Hygiene and Health Care and Emami. ### FMCG - Personal Care companies close in size

1. [Marico Ltd](https://www.sectoralpha.in/stocks/marico-ltd) ₹1,04,016 crore
2. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) ₹83,719 crore
3. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) ₹64,856 crore
4. Colgate-Palmolive (India) Ltd ₹43,423 crore
5. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) ₹23,064 crore
6. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) ₹22,239 crore
7. [Emami Ltd](https://www.sectoralpha.in/stocks/emami-ltd) ₹15,703 crore

[All 12 FMCG - Personal Care companies, largest first](https://www.sectoralpha.in/sectors/fmcg-personal-care#all-companies)

### Companies close in size in other industries

1. [Cupid Ltd](https://www.sectoralpha.in/stocks/cupid-ltd) ₹43,641 crore · Contraceptives/Protectives
2. [Petronet LNG Ltd](https://www.sectoralpha.in/stocks/petronet-lng-ltd) ₹43,425 crore · Gas Distribution
3. Colgate-Palmolive (India) Ltd ₹43,423 crore
4. [Fertilizers & Chemicals Travancore Ltd](https://www.sectoralpha.in/stocks/fertilizers-chemicals-travancore-ltd) ₹43,360 crore · Fertilisers
5. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) ₹43,322 crore · Pesticides/Agrochemicals

## What else do people ask about Colgate? ### What is Colgate's share price today? Colgate-Palmolive (India) Ltd's share price is ₹1,631.70, −27.3% over the past year. The whole company is worth ₹44,394 Cr on the market. In the last 52 weeks it traded between ₹1,597 to ₹2,255; today it is 5% of the way up from the low, 18.0% below its 200-day average (as of 3 November 2026). ### What were Colgate's latest quarterly results? Colgate-Palmolive (India) Ltd reported revenue of ₹1,706 Cr and net profit of ₹342 Cr for the Sep 2026 quarter. Revenue rose 12.2% and profit rose 4.3% compared with a year earlier. Earnings per share were ₹12.56. The operating margin was 28.0%, 3.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is Colgate's market cap? Colgate-Palmolive (India) Ltd's market capitalisation is ₹44,394 Cr at a share price of ₹1,631.70. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Colgate performing? Colgate-Palmolive (India) Ltd's share price has been falling for 97 weeks. In its latest quarter, revenue rose 12.2% and profit rose 4.3% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 15 weeks running (as of 3 November 2026). ### Will Colgate's share price go up? This page does not forecast Colgate-Palmolive (India) Ltd's share price. What it shows instead: the share price is ₹1,631.70, and it has been falling for 97 weeks. Its P/E of 32.1× is higher than 0% of its own last 11 years (as of 3 November 2026). ### Who owns Colgate? Promoters own 51.0% of Colgate-Palmolive (India) Ltd, foreign institutions 13.7%, domestic institutions 15.4% and the public 19.8% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 11.2 percentage points over 8 quarters (as of 3 November 2026). ### Does Colgate have too much debt? No, Colgate-Palmolive (India) Ltd has little debt: its debt is 0.03× its equity, and its operating profit is more than 100 times its interest bill. FY26 borrowings were ₹47.0 Cr against equity of ₹1,584 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Colgate in its business cycle? Colgate-Palmolive (India) Ltd's FY26 operating margin was 31.0%, against a 13-year range of 19.0% to 33.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 28.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Colgate story? The main question: foreign institutions moved −11.2 percentage points over 8 quarters while the business went the other way. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Colgate a stock worth studying right now? What the numbers show: Colgate-Palmolive (India) Ltd's share price has fallen more than its earnings. Earnings per share fell 7.8% in a year while the price moved −27.3%. The main open question: whether the owners’ moves turn back in line with the business. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Colgate share price forecast for 2026? What management itself guided: Balanced growth across volume, mix and price rather than predominantly price-led growth. ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india
- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india
- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india

This is research, not advice. We’re not SEBI-registered.